MIM
RYAM icon

MetLife Investment Management’s Rayonier Advanced Materials RYAM Stock Holding History

MetLife Investment Management’s Portfolio RYAM Stock Details RYAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
34,442
-577
-2% -$5.23K ﹤0.01% 2263
2026
Q1 		$388K Buy
35,019
+7,418
+27% +$66.9K ﹤0.01% 1877
2025
Q4 		$163K Sell
27,601
-2,016
-7% -$13.1K ﹤0.01% 2377
2025
Q3 		$214K Sell
29,617
-16,342
-36% -$84.2K ﹤0.01% 2281
2025
Q2 		$177K Buy
45,959
+17,118
+59% +$71.9K ﹤0.01% 2257
2025
Q1 		$166K Sell
28,841
-13,257
-31% -$93.1K ﹤0.01% 2294
2024
Q4 		$347K Buy
42,098
+5,660
+16% +$47.6K ﹤0.01% 1993
2024
Q3 		$312K Hold
36,438
– – ﹤0.01% 2046
2024
Q2 		$198K Buy
36,438
+3,815
+12% +$18.6K ﹤0.01% 2249
2024
Q1 		$156K Sell
32,623
-769
-2% -$3.27K ﹤0.01% 2325
2023
Q4 		$135K Hold
33,392
– – ﹤0.01% 2455
2023
Q3 		$118K Hold
33,392
– – ﹤0.01% 2496
2023
Q2 		$143K Buy
33,392
+5,779
+21% +$27.3K ﹤0.01% 2478
2023
Q1 		$173K Sell
27,613
-5,938
-18% -$41.4K ﹤0.01% 2302
2022
Q4 		$322K Hold
33,551
– – ﹤0.01% 1924
2022
Q3 		$106K Buy
+33,551
New +$134K ﹤0.01% 2665
2022
Q2 		– Sell
-21,779
Closed -$143K – 2899
2022
Q1 		$143K Sell
21,779
-43
-0.2% -$262 ﹤0.01% 2530
2021
Q4 		$125K Buy
21,822
+9,907
+83% +$64.4K ﹤0.01% 2324
2021
Q3 		$89.4K Sell
11,915
-12,023
-50% -$82.7K ﹤0.01% 2484
2021
Q2 		$160K Buy
23,938
+10,397
+77% +$84.7K ﹤0.01% 2295
2021
Q1 		$123K Sell
13,541
-13,378
-50% -$115K ﹤0.01% 2230
2020
Q4 		$176K Sell
26,919
-880
-3% -$4.67K ﹤0.01% 2047
2020
Q3 		$89K Buy
+27,799
New +$89.6K ﹤0.01% 2235
2019
Q3 		– Sell
-22,944
Closed -$149K – 2385
2019
Q2 		$149K Sell
22,944
-45,888
-67% -$478K ﹤0.01% 2194
2019
Q1 		$933K Buy
68,832
+45,888
+200% +$621K ﹤0.01% 1698
2018
Q4 		$244K Hold
22,944
– – ﹤0.01% 1799
2018
Q3 		$423K Hold
22,944
– – ﹤0.01% 1638
2018
Q2 		$392K Hold
22,944
– – ﹤0.01% 1555
2018
Q1 		$493K Buy
22,944
+3,768
+20% +$73.7K 0.01% 1373
2017
Q4 		$392K Buy
+19,176
New +$322K ﹤0.01% 1541

Other funds holding RYAM

CM
Condire Management Dallas, Texas $942M AUM 83.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AL
AIP LLC New York $95.2M AUM 36.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MetLife Investment Management's RYAM Position: Q2 2026 in Review

MetLife Investment Management reduced its Rayonier Advanced Materials (RYAM) stake by 1.6% in Q2 2026, selling an estimated $5.23K and leaving 34,442 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

MetLife Investment Management first reported a position in RYAM in Q4 2017 and has held it in 30 quarters since. The position peaked at $933K in Q1 2019. 188 funds tracked by Wall St. Rank hold RYAM as of Q2 2026.

  • MetLife Investment Management held 34,442 shares of Rayonier Advanced Materials worth $271K as of Q2 2026.
  • MetLife Investment Management sold 577 Rayonier Advanced Materials shares in Q2 2026, an estimated $5.23K.
  • Rayonier Advanced Materials made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2263 holding.
  • MetLife Investment Management first reported a position in Rayonier Advanced Materials in Q4 2017 and has held it in 30 quarters since.
  • MetLife Investment Management's Rayonier Advanced Materials position peaked at $933K in Q1 2019.
  • 188 funds tracked by Wall St. Rank held Rayonier Advanced Materials as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.